Design
Review
Authors
Loading...
Supports RAS blockade in hypertension; leaves open optimal intrarenal targeting for trials.
Mitchell et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: